- $553.69m
- $1.17bn
- $250.88m
- 22
- 40
- 43
- 27
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS/A | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 59.8 | 64.4 | 75.7 | 76.9 | 251 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 52.2 | 55.6 | 70.3 | 78.2 | 551 |
Operating Profit | 7.61 | 8.76 | 5.4 | -1.32 | -301 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 7.64 | 7.48 | 4.31 | -5.47 | -316 |
Provision for Income Taxes | |||||
Net Income After Taxes | 7.23 | 6.99 | 3.79 | -6 | -306 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 7.23 | 6.99 | 3.94 | -5.88 | -163 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 7.23 | 6.99 | 3.94 | -5.88 | -163 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.132 | 0.165 | 0.184 | 0.033 | -0.009 |